Medical Care
Global Macromolecular CDMO Market Research Report 2025
- Mar 14, 25
- ID: 133501
- Pages: 83
- Figures: 84
- Views: 53
The global market for Macromolecular CDMO was valued at US$ 25190 million in the year 2024 and is projected to reach a revised size of US$ 38650 million by 2031, growing at a CAGR of 6.4% during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
This report aims to provide a comprehensive presentation of the global market for Macromolecular CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macromolecular CDMO.
The Macromolecular CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macromolecular CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macromolecular CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi Biologics
GenScript Biotech Corporation
Zhenge Biotech
Samsung Biologics
Catalent, Inc.
Cambrex Corp.
AGC Biologics
Recipharm AB
Siegfried Holding
LabCorp Drug Development
FUJIFILM Diosynth Biotechnologies
Segment by Type
API Development
API Manufacturing
Segment by Application
Pharmaceutical Company
Biotechnology Company
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macromolecular CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
This report aims to provide a comprehensive presentation of the global market for Macromolecular CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macromolecular CDMO.
The Macromolecular CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macromolecular CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macromolecular CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi Biologics
GenScript Biotech Corporation
Zhenge Biotech
Samsung Biologics
Catalent, Inc.
Cambrex Corp.
AGC Biologics
Recipharm AB
Siegfried Holding
LabCorp Drug Development
FUJIFILM Diosynth Biotechnologies
Segment by Type
API Development
API Manufacturing
Segment by Application
Pharmaceutical Company
Biotechnology Company
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macromolecular CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macromolecular CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 API Development
1.2.3 API Manufacturing
1.3 Market by Application
1.3.1 Global Macromolecular CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Macromolecular CDMO Market Perspective (2020-2031)
2.2 Global Macromolecular CDMO Growth Trends by Region
2.2.1 Global Macromolecular CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Macromolecular CDMO Historic Market Size by Region (2020-2025)
2.2.3 Macromolecular CDMO Forecasted Market Size by Region (2026-2031)
2.3 Macromolecular CDMO Market Dynamics
2.3.1 Macromolecular CDMO Industry Trends
2.3.2 Macromolecular CDMO Market Drivers
2.3.3 Macromolecular CDMO Market Challenges
2.3.4 Macromolecular CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macromolecular CDMO Players by Revenue
3.1.1 Global Top Macromolecular CDMO Players by Revenue (2020-2025)
3.1.2 Global Macromolecular CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Macromolecular CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Macromolecular CDMO Revenue
3.4 Global Macromolecular CDMO Market Concentration Ratio
3.4.1 Global Macromolecular CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macromolecular CDMO Revenue in 2024
3.5 Global Key Players of Macromolecular CDMO Head office and Area Served
3.6 Global Key Players of Macromolecular CDMO, Product and Application
3.7 Global Key Players of Macromolecular CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Macromolecular CDMO Breakdown Data by Type
4.1 Global Macromolecular CDMO Historic Market Size by Type (2020-2025)
4.2 Global Macromolecular CDMO Forecasted Market Size by Type (2026-2031)
5 Macromolecular CDMO Breakdown Data by Application
5.1 Global Macromolecular CDMO Historic Market Size by Application (2020-2025)
5.2 Global Macromolecular CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Macromolecular CDMO Market Size (2020-2031)
6.2 North America Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Macromolecular CDMO Market Size by Country (2020-2025)
6.4 North America Macromolecular CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Macromolecular CDMO Market Size (2020-2031)
7.2 Europe Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Macromolecular CDMO Market Size by Country (2020-2025)
7.4 Europe Macromolecular CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macromolecular CDMO Market Size (2020-2031)
8.2 Asia-Pacific Macromolecular CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Macromolecular CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Macromolecular CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Macromolecular CDMO Market Size (2020-2031)
9.2 Latin America Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Macromolecular CDMO Market Size by Country (2020-2025)
9.4 Latin America Macromolecular CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macromolecular CDMO Market Size (2020-2031)
10.2 Middle East & Africa Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Macromolecular CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Macromolecular CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi Biologics
11.1.1 WuXi Biologics Company Details
11.1.2 WuXi Biologics Business Overview
11.1.3 WuXi Biologics Macromolecular CDMO Introduction
11.1.4 WuXi Biologics Revenue in Macromolecular CDMO Business (2020-2025)
11.1.5 WuXi Biologics Recent Development
11.2 GenScript Biotech Corporation
11.2.1 GenScript Biotech Corporation Company Details
11.2.2 GenScript Biotech Corporation Business Overview
11.2.3 GenScript Biotech Corporation Macromolecular CDMO Introduction
11.2.4 GenScript Biotech Corporation Revenue in Macromolecular CDMO Business (2020-2025)
11.2.5 GenScript Biotech Corporation Recent Development
11.3 Zhenge Biotech
11.3.1 Zhenge Biotech Company Details
11.3.2 Zhenge Biotech Business Overview
11.3.3 Zhenge Biotech Macromolecular CDMO Introduction
11.3.4 Zhenge Biotech Revenue in Macromolecular CDMO Business (2020-2025)
11.3.5 Zhenge Biotech Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Macromolecular CDMO Introduction
11.4.4 Samsung Biologics Revenue in Macromolecular CDMO Business (2020-2025)
11.4.5 Samsung Biologics Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Details
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Macromolecular CDMO Introduction
11.5.4 Catalent, Inc. Revenue in Macromolecular CDMO Business (2020-2025)
11.5.5 Catalent, Inc. Recent Development
11.6 Cambrex Corp.
11.6.1 Cambrex Corp. Company Details
11.6.2 Cambrex Corp. Business Overview
11.6.3 Cambrex Corp. Macromolecular CDMO Introduction
11.6.4 Cambrex Corp. Revenue in Macromolecular CDMO Business (2020-2025)
11.6.5 Cambrex Corp. Recent Development
11.7 AGC Biologics
11.7.1 AGC Biologics Company Details
11.7.2 AGC Biologics Business Overview
11.7.3 AGC Biologics Macromolecular CDMO Introduction
11.7.4 AGC Biologics Revenue in Macromolecular CDMO Business (2020-2025)
11.7.5 AGC Biologics Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Details
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Macromolecular CDMO Introduction
11.8.4 Recipharm AB Revenue in Macromolecular CDMO Business (2020-2025)
11.8.5 Recipharm AB Recent Development
11.9 Siegfried Holding
11.9.1 Siegfried Holding Company Details
11.9.2 Siegfried Holding Business Overview
11.9.3 Siegfried Holding Macromolecular CDMO Introduction
11.9.4 Siegfried Holding Revenue in Macromolecular CDMO Business (2020-2025)
11.9.5 Siegfried Holding Recent Development
11.10 LabCorp Drug Development
11.10.1 LabCorp Drug Development Company Details
11.10.2 LabCorp Drug Development Business Overview
11.10.3 LabCorp Drug Development Macromolecular CDMO Introduction
11.10.4 LabCorp Drug Development Revenue in Macromolecular CDMO Business (2020-2025)
11.10.5 LabCorp Drug Development Recent Development
11.11 FUJIFILM Diosynth Biotechnologies
11.11.1 FUJIFILM Diosynth Biotechnologies Company Details
11.11.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.11.3 FUJIFILM Diosynth Biotechnologies Macromolecular CDMO Introduction
11.11.4 FUJIFILM Diosynth Biotechnologies Revenue in Macromolecular CDMO Business (2020-2025)
11.11.5 FUJIFILM Diosynth Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macromolecular CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 API Development
1.2.3 API Manufacturing
1.3 Market by Application
1.3.1 Global Macromolecular CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Macromolecular CDMO Market Perspective (2020-2031)
2.2 Global Macromolecular CDMO Growth Trends by Region
2.2.1 Global Macromolecular CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Macromolecular CDMO Historic Market Size by Region (2020-2025)
2.2.3 Macromolecular CDMO Forecasted Market Size by Region (2026-2031)
2.3 Macromolecular CDMO Market Dynamics
2.3.1 Macromolecular CDMO Industry Trends
2.3.2 Macromolecular CDMO Market Drivers
2.3.3 Macromolecular CDMO Market Challenges
2.3.4 Macromolecular CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macromolecular CDMO Players by Revenue
3.1.1 Global Top Macromolecular CDMO Players by Revenue (2020-2025)
3.1.2 Global Macromolecular CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Macromolecular CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Macromolecular CDMO Revenue
3.4 Global Macromolecular CDMO Market Concentration Ratio
3.4.1 Global Macromolecular CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macromolecular CDMO Revenue in 2024
3.5 Global Key Players of Macromolecular CDMO Head office and Area Served
3.6 Global Key Players of Macromolecular CDMO, Product and Application
3.7 Global Key Players of Macromolecular CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Macromolecular CDMO Breakdown Data by Type
4.1 Global Macromolecular CDMO Historic Market Size by Type (2020-2025)
4.2 Global Macromolecular CDMO Forecasted Market Size by Type (2026-2031)
5 Macromolecular CDMO Breakdown Data by Application
5.1 Global Macromolecular CDMO Historic Market Size by Application (2020-2025)
5.2 Global Macromolecular CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Macromolecular CDMO Market Size (2020-2031)
6.2 North America Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Macromolecular CDMO Market Size by Country (2020-2025)
6.4 North America Macromolecular CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Macromolecular CDMO Market Size (2020-2031)
7.2 Europe Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Macromolecular CDMO Market Size by Country (2020-2025)
7.4 Europe Macromolecular CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macromolecular CDMO Market Size (2020-2031)
8.2 Asia-Pacific Macromolecular CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Macromolecular CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Macromolecular CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Macromolecular CDMO Market Size (2020-2031)
9.2 Latin America Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Macromolecular CDMO Market Size by Country (2020-2025)
9.4 Latin America Macromolecular CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macromolecular CDMO Market Size (2020-2031)
10.2 Middle East & Africa Macromolecular CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Macromolecular CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Macromolecular CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi Biologics
11.1.1 WuXi Biologics Company Details
11.1.2 WuXi Biologics Business Overview
11.1.3 WuXi Biologics Macromolecular CDMO Introduction
11.1.4 WuXi Biologics Revenue in Macromolecular CDMO Business (2020-2025)
11.1.5 WuXi Biologics Recent Development
11.2 GenScript Biotech Corporation
11.2.1 GenScript Biotech Corporation Company Details
11.2.2 GenScript Biotech Corporation Business Overview
11.2.3 GenScript Biotech Corporation Macromolecular CDMO Introduction
11.2.4 GenScript Biotech Corporation Revenue in Macromolecular CDMO Business (2020-2025)
11.2.5 GenScript Biotech Corporation Recent Development
11.3 Zhenge Biotech
11.3.1 Zhenge Biotech Company Details
11.3.2 Zhenge Biotech Business Overview
11.3.3 Zhenge Biotech Macromolecular CDMO Introduction
11.3.4 Zhenge Biotech Revenue in Macromolecular CDMO Business (2020-2025)
11.3.5 Zhenge Biotech Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Macromolecular CDMO Introduction
11.4.4 Samsung Biologics Revenue in Macromolecular CDMO Business (2020-2025)
11.4.5 Samsung Biologics Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Details
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Macromolecular CDMO Introduction
11.5.4 Catalent, Inc. Revenue in Macromolecular CDMO Business (2020-2025)
11.5.5 Catalent, Inc. Recent Development
11.6 Cambrex Corp.
11.6.1 Cambrex Corp. Company Details
11.6.2 Cambrex Corp. Business Overview
11.6.3 Cambrex Corp. Macromolecular CDMO Introduction
11.6.4 Cambrex Corp. Revenue in Macromolecular CDMO Business (2020-2025)
11.6.5 Cambrex Corp. Recent Development
11.7 AGC Biologics
11.7.1 AGC Biologics Company Details
11.7.2 AGC Biologics Business Overview
11.7.3 AGC Biologics Macromolecular CDMO Introduction
11.7.4 AGC Biologics Revenue in Macromolecular CDMO Business (2020-2025)
11.7.5 AGC Biologics Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Details
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Macromolecular CDMO Introduction
11.8.4 Recipharm AB Revenue in Macromolecular CDMO Business (2020-2025)
11.8.5 Recipharm AB Recent Development
11.9 Siegfried Holding
11.9.1 Siegfried Holding Company Details
11.9.2 Siegfried Holding Business Overview
11.9.3 Siegfried Holding Macromolecular CDMO Introduction
11.9.4 Siegfried Holding Revenue in Macromolecular CDMO Business (2020-2025)
11.9.5 Siegfried Holding Recent Development
11.10 LabCorp Drug Development
11.10.1 LabCorp Drug Development Company Details
11.10.2 LabCorp Drug Development Business Overview
11.10.3 LabCorp Drug Development Macromolecular CDMO Introduction
11.10.4 LabCorp Drug Development Revenue in Macromolecular CDMO Business (2020-2025)
11.10.5 LabCorp Drug Development Recent Development
11.11 FUJIFILM Diosynth Biotechnologies
11.11.1 FUJIFILM Diosynth Biotechnologies Company Details
11.11.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.11.3 FUJIFILM Diosynth Biotechnologies Macromolecular CDMO Introduction
11.11.4 FUJIFILM Diosynth Biotechnologies Revenue in Macromolecular CDMO Business (2020-2025)
11.11.5 FUJIFILM Diosynth Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Macromolecular CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of API Development
Table 3. Key Players of API Manufacturing
Table 4. Global Macromolecular CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Macromolecular CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Macromolecular CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Macromolecular CDMO Market Share by Region (2020-2025)
Table 8. Global Macromolecular CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Macromolecular CDMO Market Share by Region (2026-2031)
Table 10. Macromolecular CDMO Market Trends
Table 11. Macromolecular CDMO Market Drivers
Table 12. Macromolecular CDMO Market Challenges
Table 13. Macromolecular CDMO Market Restraints
Table 14. Global Macromolecular CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Macromolecular CDMO Market Share by Players (2020-2025)
Table 16. Global Top Macromolecular CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macromolecular CDMO as of 2024)
Table 17. Ranking of Global Top Macromolecular CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Macromolecular CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Macromolecular CDMO, Headquarters and Area Served
Table 20. Global Key Players of Macromolecular CDMO, Product and Application
Table 21. Global Key Players of Macromolecular CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Macromolecular CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Macromolecular CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Macromolecular CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Macromolecular CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Macromolecular CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Macromolecular CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Macromolecular CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Macromolecular CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Macromolecular CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Macromolecular CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Macromolecular CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. WuXi Biologics Company Details
Table 47. WuXi Biologics Business Overview
Table 48. WuXi Biologics Macromolecular CDMO Product
Table 49. WuXi Biologics Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 50. WuXi Biologics Recent Development
Table 51. GenScript Biotech Corporation Company Details
Table 52. GenScript Biotech Corporation Business Overview
Table 53. GenScript Biotech Corporation Macromolecular CDMO Product
Table 54. GenScript Biotech Corporation Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 55. GenScript Biotech Corporation Recent Development
Table 56. Zhenge Biotech Company Details
Table 57. Zhenge Biotech Business Overview
Table 58. Zhenge Biotech Macromolecular CDMO Product
Table 59. Zhenge Biotech Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 60. Zhenge Biotech Recent Development
Table 61. Samsung Biologics Company Details
Table 62. Samsung Biologics Business Overview
Table 63. Samsung Biologics Macromolecular CDMO Product
Table 64. Samsung Biologics Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 65. Samsung Biologics Recent Development
Table 66. Catalent, Inc. Company Details
Table 67. Catalent, Inc. Business Overview
Table 68. Catalent, Inc. Macromolecular CDMO Product
Table 69. Catalent, Inc. Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 70. Catalent, Inc. Recent Development
Table 71. Cambrex Corp. Company Details
Table 72. Cambrex Corp. Business Overview
Table 73. Cambrex Corp. Macromolecular CDMO Product
Table 74. Cambrex Corp. Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 75. Cambrex Corp. Recent Development
Table 76. AGC Biologics Company Details
Table 77. AGC Biologics Business Overview
Table 78. AGC Biologics Macromolecular CDMO Product
Table 79. AGC Biologics Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 80. AGC Biologics Recent Development
Table 81. Recipharm AB Company Details
Table 82. Recipharm AB Business Overview
Table 83. Recipharm AB Macromolecular CDMO Product
Table 84. Recipharm AB Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 85. Recipharm AB Recent Development
Table 86. Siegfried Holding Company Details
Table 87. Siegfried Holding Business Overview
Table 88. Siegfried Holding Macromolecular CDMO Product
Table 89. Siegfried Holding Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 90. Siegfried Holding Recent Development
Table 91. LabCorp Drug Development Company Details
Table 92. LabCorp Drug Development Business Overview
Table 93. LabCorp Drug Development Macromolecular CDMO Product
Table 94. LabCorp Drug Development Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 95. LabCorp Drug Development Recent Development
Table 96. FUJIFILM Diosynth Biotechnologies Company Details
Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies Macromolecular CDMO Product
Table 99. FUJIFILM Diosynth Biotechnologies Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 100. FUJIFILM Diosynth Biotechnologies Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Macromolecular CDMO Picture
Figure 2. Global Macromolecular CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Macromolecular CDMO Market Share by Type: 2024 VS 2031
Figure 4. API Development Features
Figure 5. API Manufacturing Features
Figure 6. Global Macromolecular CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Macromolecular CDMO Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Company Case Studies
Figure 10. Macromolecular CDMO Report Years Considered
Figure 11. Global Macromolecular CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Macromolecular CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Macromolecular CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Macromolecular CDMO Market Share by Players in 2024
Figure 15. Global Top Macromolecular CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macromolecular CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Macromolecular CDMO Revenue in 2024
Figure 17. North America Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Macromolecular CDMO Market Share by Country (2020-2031)
Figure 19. United States Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Macromolecular CDMO Market Share by Country (2020-2031)
Figure 23. Germany Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Macromolecular CDMO Market Share by Region (2020-2031)
Figure 31. China Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Macromolecular CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Macromolecular CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. WuXi Biologics Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 47. GenScript Biotech Corporation Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 48. Zhenge Biotech Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 49. Samsung Biologics Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 50. Catalent, Inc. Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 51. Cambrex Corp. Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 52. AGC Biologics Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 53. Recipharm AB Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 54. Siegfried Holding Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 55. LabCorp Drug Development Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Macromolecular CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of API Development
Table 3. Key Players of API Manufacturing
Table 4. Global Macromolecular CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Macromolecular CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Macromolecular CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Macromolecular CDMO Market Share by Region (2020-2025)
Table 8. Global Macromolecular CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Macromolecular CDMO Market Share by Region (2026-2031)
Table 10. Macromolecular CDMO Market Trends
Table 11. Macromolecular CDMO Market Drivers
Table 12. Macromolecular CDMO Market Challenges
Table 13. Macromolecular CDMO Market Restraints
Table 14. Global Macromolecular CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Macromolecular CDMO Market Share by Players (2020-2025)
Table 16. Global Top Macromolecular CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macromolecular CDMO as of 2024)
Table 17. Ranking of Global Top Macromolecular CDMO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Macromolecular CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Macromolecular CDMO, Headquarters and Area Served
Table 20. Global Key Players of Macromolecular CDMO, Product and Application
Table 21. Global Key Players of Macromolecular CDMO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Macromolecular CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Macromolecular CDMO Revenue Market Share by Type (2020-2025)
Table 25. Global Macromolecular CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Macromolecular CDMO Revenue Market Share by Type (2026-2031)
Table 27. Global Macromolecular CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Macromolecular CDMO Revenue Market Share by Application (2020-2025)
Table 29. Global Macromolecular CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Macromolecular CDMO Revenue Market Share by Application (2026-2031)
Table 31. North America Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Macromolecular CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Macromolecular CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Macromolecular CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Macromolecular CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Macromolecular CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Macromolecular CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 46. WuXi Biologics Company Details
Table 47. WuXi Biologics Business Overview
Table 48. WuXi Biologics Macromolecular CDMO Product
Table 49. WuXi Biologics Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 50. WuXi Biologics Recent Development
Table 51. GenScript Biotech Corporation Company Details
Table 52. GenScript Biotech Corporation Business Overview
Table 53. GenScript Biotech Corporation Macromolecular CDMO Product
Table 54. GenScript Biotech Corporation Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 55. GenScript Biotech Corporation Recent Development
Table 56. Zhenge Biotech Company Details
Table 57. Zhenge Biotech Business Overview
Table 58. Zhenge Biotech Macromolecular CDMO Product
Table 59. Zhenge Biotech Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 60. Zhenge Biotech Recent Development
Table 61. Samsung Biologics Company Details
Table 62. Samsung Biologics Business Overview
Table 63. Samsung Biologics Macromolecular CDMO Product
Table 64. Samsung Biologics Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 65. Samsung Biologics Recent Development
Table 66. Catalent, Inc. Company Details
Table 67. Catalent, Inc. Business Overview
Table 68. Catalent, Inc. Macromolecular CDMO Product
Table 69. Catalent, Inc. Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 70. Catalent, Inc. Recent Development
Table 71. Cambrex Corp. Company Details
Table 72. Cambrex Corp. Business Overview
Table 73. Cambrex Corp. Macromolecular CDMO Product
Table 74. Cambrex Corp. Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 75. Cambrex Corp. Recent Development
Table 76. AGC Biologics Company Details
Table 77. AGC Biologics Business Overview
Table 78. AGC Biologics Macromolecular CDMO Product
Table 79. AGC Biologics Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 80. AGC Biologics Recent Development
Table 81. Recipharm AB Company Details
Table 82. Recipharm AB Business Overview
Table 83. Recipharm AB Macromolecular CDMO Product
Table 84. Recipharm AB Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 85. Recipharm AB Recent Development
Table 86. Siegfried Holding Company Details
Table 87. Siegfried Holding Business Overview
Table 88. Siegfried Holding Macromolecular CDMO Product
Table 89. Siegfried Holding Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 90. Siegfried Holding Recent Development
Table 91. LabCorp Drug Development Company Details
Table 92. LabCorp Drug Development Business Overview
Table 93. LabCorp Drug Development Macromolecular CDMO Product
Table 94. LabCorp Drug Development Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 95. LabCorp Drug Development Recent Development
Table 96. FUJIFILM Diosynth Biotechnologies Company Details
Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies Macromolecular CDMO Product
Table 99. FUJIFILM Diosynth Biotechnologies Revenue in Macromolecular CDMO Business (2020-2025) & (US$ Million)
Table 100. FUJIFILM Diosynth Biotechnologies Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Macromolecular CDMO Picture
Figure 2. Global Macromolecular CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Macromolecular CDMO Market Share by Type: 2024 VS 2031
Figure 4. API Development Features
Figure 5. API Manufacturing Features
Figure 6. Global Macromolecular CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Macromolecular CDMO Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Company Case Studies
Figure 10. Macromolecular CDMO Report Years Considered
Figure 11. Global Macromolecular CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Macromolecular CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Macromolecular CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Macromolecular CDMO Market Share by Players in 2024
Figure 15. Global Top Macromolecular CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macromolecular CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Macromolecular CDMO Revenue in 2024
Figure 17. North America Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Macromolecular CDMO Market Share by Country (2020-2031)
Figure 19. United States Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Macromolecular CDMO Market Share by Country (2020-2031)
Figure 23. Germany Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Macromolecular CDMO Market Share by Region (2020-2031)
Figure 31. China Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Macromolecular CDMO Market Share by Country (2020-2031)
Figure 39. Mexico Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Macromolecular CDMO Market Share by Country (2020-2031)
Figure 43. Turkey Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Macromolecular CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. WuXi Biologics Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 47. GenScript Biotech Corporation Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 48. Zhenge Biotech Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 49. Samsung Biologics Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 50. Catalent, Inc. Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 51. Cambrex Corp. Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 52. AGC Biologics Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 53. Recipharm AB Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 54. Siegfried Holding Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 55. LabCorp Drug Development Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Macromolecular CDMO Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232